True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report

True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report

Donor cell leukemia (DCL) is a rare complication after allogeneic hematopoietic stem cell transplantation (HSCT) accounting for 0.1% of relapses and presenting as secondary leukemia of donor origin. Distinct in phenotype and cytogenetics from the original leukemia, DCL’s clinical challenge lies in i...

Full description

Bibliographic Details
Main Authors: Michèle Hoffmann, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Ulrike Bacher, Thomas Pabst
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Current Oncology
Subjects:
donor cell leukemia
allogeneic hematopoietic stem cell transplantation
mixed-phenotype acute leukemia
chimerism
leukemogenesis
Online Access:https://www.mdpi.com/1718-7729/31/4/153

Internet

https://www.mdpi.com/1718-7729/31/4/153

Similar Items